GI Alpha-Gal Study

Clinical trial NCT06268717 · COMPLETED

Trial details

NCT number: NCT06268717
Sponsor: University of North Carolina, Chapel Hill
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Alpha-Gal Syndrome Irritable Bowel Syndrome Diarrhea Abdominal Pain Vomiting

Start date: 2023-10-17
Primary completion: 2026-06-02
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.